| Nome |
# |
|
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE, file e0c35a4c-f6ef-5883-e053-d805fe0ac580
|
145
|
|
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis, file 20820536-3281-4182-b88b-770b8afa3f8c
|
19
|
|
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review, file 872defbc-9a7e-44a9-ae03-577c5245d11c
|
14
|
|
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network, file 6eb3eefe-5593-4848-8d6f-25434b433f9e
|
10
|
|
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis, file 799a269a-d8bb-4437-855e-39e7db9f37ce
|
10
|
|
Generalized morphea after COVID-19 vaccines: a case series, file 98826ff8-44c1-4ed7-96c3-ac086214f7be
|
10
|
|
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis, file eefbd187-2ab9-47b2-8d30-a04246eaba7c
|
9
|
|
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia, file 294c13d4-7a13-455f-990e-2eb2c5c42ca8
|
8
|
|
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry, file 55cb9e99-2ff7-4d43-a1a0-9097a51acc81
|
8
|
|
The association between body mass index and fibromyalgia severity: Data from a cross-sectional survey of 2339 patients, file ae5a2383-2703-4bd9-b45f-c91f978e7dd3
|
8
|
|
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial (Nature Medicine, (2021), 27, 10, (1752-1760), 10.1038/s41591-021-01499-z), file b42d46a1-c9bc-4ff3-b647-6cf8da3907d3
|
8
|
|
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients, file 23a6035c-ca14-4c96-9037-991a2249933a
|
7
|
|
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial, file 456a83df-e4bd-4ed2-90eb-aabad8a72dd0
|
7
|
|
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database, file 6e3f23ba-56a1-434a-963a-6d88aa8b8dee
|
7
|
|
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9), file 83f9bf70-48cf-426d-a55f-53805325bf2e
|
7
|
|
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database, file 8b0c44a3-f3af-4065-8bbc-198b7fdd1c72
|
7
|
|
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment, file e0c35a4c-ee46-5883-e053-d805fe0ac580
|
7
|
|
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities, file 10fbee28-4784-4465-b608-d3547e3c1e68
|
6
|
|
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE, file 68590af8-d226-4ff4-bcaf-ec7a8eb3a5ff
|
6
|
|
The right place for IL-1 inhibition in COVID-19, file b53be75d-fd00-47af-a247-e5061a23da1b
|
6
|
|
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination, file bc445f07-d31b-48df-a333-f5fd40397c44
|
6
|
|
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature, file d9947de7-582b-4d18-9b01-2df9b009fd44
|
6
|
|
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease, file e0c35a4c-fdba-5883-e053-d805fe0ac580
|
6
|
|
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees, file 8581ba18-3345-4e04-9fb5-14b39222cd57
|
5
|
|
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life, file bf83215e-e3d2-48f7-875f-abd8a1cd0f73
|
5
|
|
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE, file e0c35a4c-f593-5883-e053-d805fe0ac580
|
5
|
|
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group, file 386ce159-c260-419c-93a1-5b24e556d2e8
|
4
|
|
Serum IgG4 level predicts COVID-19 related mortality, file 52a5ddd0-e13f-48e9-b08a-21f3803a0555
|
4
|
|
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates, file 5a872834-604e-4392-ada7-ee067a7bdf45
|
4
|
|
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation, file ac99905d-c527-475f-a723-7ca29e2989c8
|
4
|
|
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey, file d68e35f8-bbd8-46d5-8a55-06a947c8a3ea
|
4
|
|
Testosterone in males with COVID-19: A twelve-month cohort study, file ddc59148-d2ca-40d7-ade6-5831c5226657
|
4
|
|
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network, file 67ecda66-eaba-41d8-b40d-8256d8f04c87
|
3
|
|
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network, file 7a301a95-d0ae-4d0a-b379-09adc655d7df
|
3
|
|
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease, file e0c35a4b-e5bc-5883-e053-d805fe0ac580
|
3
|
|
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease, file e0c35a4c-93df-5883-e053-d805fe0ac580
|
3
|
|
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study, file f11dfdea-943b-4c40-8bfc-43a7f416a236
|
3
|
|
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort', file fbf95022-4ad8-42dd-9822-b4503eefe8c8
|
3
|
|
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis, file 16a803e1-652d-48af-8c61-6da1700b466a
|
2
|
|
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report, file 5ec70d5c-4544-412b-8444-4e2b2c23b5fc
|
2
|
|
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection, file 7dcb33f9-ff3c-4e67-a4ba-e95f125281b3
|
2
|
|
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang, file b84a5c19-8d9c-4c15-a219-c662719fd386
|
2
|
|
A relapsing inflammatory syndrome and HHV-8, file e0c35a4b-d740-5883-e053-d805fe0ac580
|
2
|
|
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage, file e0c35a4b-f8d9-5883-e053-d805fe0ac580
|
2
|
|
Tocilizumab in patients with multisystem ErdheimâChester disease, file e0c35a4c-12b3-5883-e053-d805fe0ac580
|
2
|
|
Treating Pulmonary Silicosis by Blocking Interleukin 1, file e0c35a4c-973f-5883-e053-d805fe0ac580
|
2
|
|
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease., file e0c35a4c-9745-5883-e053-d805fe0ac580
|
2
|
|
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients, file e0c35a4c-f0f7-5883-e053-d805fe0ac580
|
2
|
|
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4-
RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE, file e0c35a4c-f1c7-5883-e053-d805fe0ac580
|
2
|
|
Stranger months: how SARS-CoV-2, fear of contagion, and lockdown measures impacted attendance and clinical activity during February and March 2020 at an urban Emergency Department in Milan, file e0c35a4c-fcdb-5883-e053-d805fe0ac580
|
2
|
|
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls, file e0c35a4d-0055-5883-e053-d805fe0ac580
|
2
|
|
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort, file 21c01087-1c52-4883-b5a4-935ba13f4099
|
1
|
|
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981](S1568997221002615)(10.1016/j.autrev.2021.102981), file 2756be93-4500-4041-a334-95eb4a9bb9de
|
1
|
|
Myocardial infarction in giant cell arteritis: It is all a matter of balance, file 3192672c-3110-470a-9fac-723e5509ba96
|
1
|
|
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias, file 346fe3b3-861e-40db-920f-b83bd8cd2fa1
|
1
|
|
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy, file 3589b16c-39dc-46c9-a301-1a150ac4af18
|
1
|
|
Response to: Ͽ Correspondence on Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: A monocentric survey' by Comarmond et al, file 3a8710f5-caff-4ce2-b327-d8126f67517b
|
1
|
|
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management, file 4046cae9-2f03-4bc9-a300-b10916ca690f
|
1
|
|
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study, file 451d154d-e752-4d93-9f88-1c7e20a47a1b
|
1
|
|
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply, file 740e7f3f-8e8f-4d16-ac16-2dfc612d58b7
|
1
|
|
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum, file 84f6d02e-5e1f-4ac2-aff7-6ba95c5b4632
|
1
|
|
Erratum: Common diagnoses in internal medicine in Europe 2009: A pan-European, multi-centre survey (European Journal of Internal Medicine (2010) 21:5 (449-452)), file b16139ad-bb6a-49e6-acea-aed7c7320ceb
|
1
|
|
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology, file b80de664-2394-4326-a27d-99d1e0750fb5
|
1
|
|
One year later: The case of tocilizumab in COVID-19, file c9d8f2a2-74c2-4292-890c-43d589457929
|
1
|
|
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle, file d5c9d817-47c4-4ca6-9555-50364740aab3
|
1
|
|
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab, file e0c35a4b-d9aa-5883-e053-d805fe0ac580
|
1
|
|
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case, file e0c35a4b-db0d-5883-e053-d805fe0ac580
|
1
|
|
Erdheim-Chester disease., file e0c35a4b-e2b0-5883-e053-d805fe0ac580
|
1
|
|
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients, file e0c35a4b-e534-5883-e053-d805fe0ac580
|
1
|
|
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity, file e0c35a4b-eccc-5883-e053-d805fe0ac580
|
1
|
|
TNF-alpha in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab, file e0c35a4b-f84c-5883-e053-d805fe0ac580
|
1
|
|
TNF-alpha in Erdheim-Chester disease pericardial effusion promotes endothelial leakage in vitro and is neutralized by infliximab, file e0c35a4b-f84d-5883-e053-d805fe0ac580
|
1
|
|
Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure, file e0c35a4c-1917-5883-e053-d805fe0ac580
|
1
|
|
Efficacy and safety of biological agents in adult-onset Still's disease, file e0c35a4c-9741-5883-e053-d805fe0ac580
|
1
|
|
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition, file e0c35a4c-9910-5883-e053-d805fe0ac580
|
1
|
|
Prevalence of Takayasu arteritis in young women with acute ischemic heart disease, file e0c35a4c-9912-5883-e053-d805fe0ac580
|
1
|
|
Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation, file e0c35a4c-9917-5883-e053-d805fe0ac580
|
1
|
|
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis, file e0c35a4c-9cbb-5883-e053-d805fe0ac580
|
1
|
|
Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer, file e0c35a4c-9d93-5883-e053-d805fe0ac580
|
1
|
|
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout, file e0c35a4c-9d95-5883-e053-d805fe0ac580
|
1
|
|
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience, file e0c35a4c-9d97-5883-e053-d805fe0ac580
|
1
|
|
Treating Life-Threatening Myocarditis by Blocking Interleukin-1, file e0c35a4c-9f60-5883-e053-d805fe0ac580
|
1
|
|
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance, file e0c35a4c-a0b7-5883-e053-d805fe0ac580
|
1
|
|
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli, file e0c35a4c-a8c9-5883-e053-d805fe0ac580
|
1
|
|
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19, file e0c35a4c-cb3e-5883-e053-d805fe0ac580
|
1
|
|
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency, file e0c35a4c-deba-5883-e053-d805fe0ac580
|
1
|
|
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation, file e0c35a4c-e0dc-5883-e053-d805fe0ac580
|
1
|
|
Drug retention rates of biological agents in adult onset Still's disease, file e0c35a4c-ecf9-5883-e053-d805fe0ac580
|
1
|
|
CLINICAL PHENOTYPES OF IGG4-
RELATED DISEASE REFLECT
DIFFERENCES IN EPIDEMIOLOGICAL
FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES, file e0c35a4c-ed2f-5883-e053-d805fe0ac580
|
1
|
|
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series, file e0c35a4c-ed75-5883-e053-d805fe0ac580
|
1
|
|
MULTIDIRECTIONAL DYSFUNCTION OF THE IMMUNE RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS, file e0c35a4c-ee4f-5883-e053-d805fe0ac580
|
1
|
|
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine, file e0c35a4c-eef0-5883-e053-d805fe0ac580
|
1
|
|
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients, file e0c35a4c-f571-5883-e053-d805fe0ac580
|
1
|
|
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE, file e0c35a4c-f6de-5883-e053-d805fe0ac580
|
1
|
|
Effects of glucocorticoids and methotrexate-based therapeutic regimens on B cell subpopulations in patients with IgG4-related disease., file e0c35a4c-f6e7-5883-e053-d805fe0ac580
|
1
|
|
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use, file e0c35a4c-f71c-5883-e053-d805fe0ac580
|
1
|
|
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease., file e0c35a4c-f74a-5883-e053-d805fe0ac580
|
1
|
|
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE
OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE, file e0c35a4c-f74b-5883-e053-d805fe0ac580
|
1
|
|
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19, file e0c35a4c-fa35-5883-e053-d805fe0ac580
|
1
|
|
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19, file e0c35a4c-fb06-5883-e053-d805fe0ac580
|
1
|
| Totale |
459 |